EXPRESS: Early Blood RNA Clearance and Protein Fraction Profiles Predict Treatment Outcomes in Cats with Effusive FIP.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

GS-441524 - Copycat Sci

Lagevrio (molnupiravir) - Ridgeback Biotherap, Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/41294213

Chikara Satake; Chisako Shiozumi; Tomomi Takano; Tomoyoshi Doki; Tsuyoshi Kamiyoshi

Nov 26, 2025